GeneticsFrontiers in EndocrinologyPeer-reviewed
Apolipoprotein B and Interleukin 1 Receptor Antagonist: Reversing the Risk of Coronary Heart Disease
Fangkun Yang, Ning Huangfu, Jiaxi Shen…·Shuai Yuan
This study uses Mendelian randomization to show IL-1Ra increases CHD risk, which is reversed by apolipoprotein B adjustment and lifestyle interventions.
3 citations